Chronic CD40L blockade is required for long-term cardiac allograft survival with a clinically relevant CTLA4-Ig dosing regimen

Frontiers in immunology

Lukas W Unger, Moritz Muckenhuber, Benedikt Mahr, …, Nicolas Granofszky, Heinz Regele, Thomas Wekerle

• DOI: 10.3389/fimmu.2022.1060576
• PMID: 36569922
• PMCID: PMC9773869